文献速递消化道肿瘤放疗放疗物理与技术

胃癌放疗中胰腺吸收剂量的分析

The analysis of absorbed dose by pancreas during gastric cancer radiotherapy.
PubMed 文献 · Radiother Oncol · 2020-07-15

该研究重新分析127例接受术前或术后放化疗的胃癌患者,总剂量45 Gy分25次照射,基于CT勾画胰腺头、体、尾并分析吸收剂量。结果显示全胰腺80%体积吸收至少44.5 Gy,体、尾、头分别吸收该剂量的100%、90%、70%,全胰腺平均剂量32–48 Gy(均值44 Gy)。45 Gy可导致亚临床胰腺功能不全(低脂酶血症和低淀粉酶血症),但不会引起症状性胰腺损伤。

要点

  • 全胰腺80%体积吸收至少44.5 Gy,体、尾、头分别吸收该剂量的100%、90%、70%。
  • 全胰腺平均剂量范围为32–48 Gy,均值为44 Gy。
  • 45 Gy可致亚临床胰腺功能不全,但不引起症状性胰腺损伤。

核心结论

  • 胃癌放疗总剂量45 Gy分25次可导致亚临床胰腺功能不全(低脂酶血症和低淀粉酶血症),但不会引起症状性胰腺损伤。

研究设计与样本

  • 重新分析127例接受术前或术后放化疗的胃癌患者,总剂量45 Gy分25次照射。
  • 基于放疗计划CT勾画胰腺并分为头、体、尾三部分以确定吸收剂量。

主要发现

  • 全胰腺80%体积吸收至少44.5 Gy,体、尾、头分别吸收该剂量的100%、90%、70%。
  • 全胰腺平均剂量范围为32–48 Gy,均值为44 Gy。
  • 45 Gy可导致亚临床胰腺功能不全(低脂酶血症和低淀粉酶血症),但不引起症状性胰腺损伤。

关键数值与推荐

  • 全胰腺80%体积吸收至少44.5 Gy。
  • 胰腺体、尾、头分别吸收44.5 Gy的100%、90%、70%。
  • 全胰腺平均剂量范围为32–48 Gy,均值为44 Gy。

临床怎么用

  • 胃癌放疗时胰腺并非无共同剂量约束的器官,45 Gy分25次可致亚临床功能不全但无症状性损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The toxicity of radiotherapy is a very important issue in the everyday work of radiation oncologist. The tolerance to certain doses of radiotherapy in organs at risk determines the safety of radiotherapy. Despite the increasing number of publications concerning the injury of the pancreas after radiotherapy, this organ does not have common directives. We decided to reanalyse our previously published data in terms of the dose of radiation absorbed by the pancreas to determine a dose-effect relationship with the use of radiation-induced hypoamylasaemia and hypolipasaemia. MATERIALS AND METHODS: We reanalysed a group of 127 gastric cancer patients after preoperative or postoperative chemoradiotherapy who were treated with a total dose of 45 Gy administered in 25 fractions. To identify the absorbed doses, the pancreas was contoured based on the CT scans used for radiotherapy planning and divided into anatomical parts: the head, the body and the tail. RESULTS: We found that 80% of the whole pancreatic volume absorbed at least 44.5 Gy. The body, tail and head absorbed 100%, 90% and 70% of the abovementioned dose, respectively. The mean dose absorbed by the whole pancreas ranged from 32 to 48 Gy, with a mean of 44 Gy. A total dose of 45 Gy administered to gastric cancer patients can lead to subclinical insufficiency of the pancreas (hypolipasaemia and hypoamylasaemia). This dose is not able to cause symptomatic damage to the pancreas.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Polanowski P, Wydmański J, Tukiendorf A, et al. The analysis of absorbed dose by pancreas during gastric cancer radiotherapy. Radiother Oncol. 2020. PMID: 32679311. doi:10.1016/j.radonc.2020.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。